These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12969746)

  • 21. Effect of monoamine uptake inhibitors on norepinephrine-stimulated phosphatidylinositol hydrolysis in rat cortex.
    Mosaddeghi M; Moerschbaecher JM; Gonzales RA
    Biochem Pharmacol; 1989 Jan; 38(2):257-62. PubMed ID: 2536541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices.
    Johnson MP; Hoffman AJ; Nichols DE
    Eur J Pharmacol; 1986 Dec; 132(2-3):269-76. PubMed ID: 2880735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
    Callahan PM; Appel JB
    J Pharmacol Exp Ther; 1988 Sep; 246(3):866-70. PubMed ID: 2901488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys.
    Beardsley PM; Balster RL; Harris LS
    Drug Alcohol Depend; 1986 Oct; 18(2):149-57. PubMed ID: 2877842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies of dioxole ring substituted 3,4-methylenedioxyamphetamine (MDA) analogues.
    Nichols DE; Oberlender R; Burris K; Hoffman AJ; Johnson MP
    Pharmacol Biochem Behav; 1989 Nov; 34(3):571-6. PubMed ID: 2623014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of optical isomers of 3,4-methylenedioxymethamphetamine (MDMA) on stereotyped behavior in rats.
    Hiramatsu M; Nabeshima T; Kameyama T; Maeda Y; Cho AK
    Pharmacol Biochem Behav; 1989 Jun; 33(2):343-7. PubMed ID: 2573077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of gender differences in the cardiovascular actions of direct and indirect sympathomimetic stimulants including cathinone in the anaesthetized rat.
    Alsufyani HA; Docherty JR
    Auton Autacoid Pharmacol; 2016 Jan; 36(1-2):14-9. PubMed ID: 27534387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thioether metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine inhibit human serotonin transporter (hSERT) function and simultaneously stimulate dopamine uptake into hSERT-expressing SK-N-MC cells.
    Jones DC; Lau SS; Monks TJ
    J Pharmacol Exp Ther; 2004 Oct; 311(1):298-306. PubMed ID: 15169827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MDMA (ecstasy) effects on cultured serotonergic neurons: evidence for Ca2(+)-dependent toxicity linked to release.
    Azmitia EC; Murphy RB; Whitaker-Azmitia PM
    Brain Res; 1990 Feb; 510(1):97-103. PubMed ID: 1969761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors.
    Lyon RA; Glennon RA; Titeler M
    Psychopharmacology (Berl); 1986; 88(4):525-6. PubMed ID: 2871581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral suppression following 3,4-methylenenedioxymethamphetamine.
    Kulmala HK; Boja JW; Schechter MD
    Life Sci; 1987 Sep; 41(11):1425-9. PubMed ID: 2887995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MDMA: further evidence that its action in the medial prefrontal cortex is mediated by the serotonergic system.
    Pan HS; Wang RY
    Brain Res; 1991 Jan; 539(2):332-6. PubMed ID: 1675911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of the Syva EMIT and Abbott TDx amphetamine immunoassays to the detection of 3,4-methylene-dioxymethamphetamine (MDMA) and 3,4-methylene-dioxyethamphetamine (MDEA) in urine.
    Kunsman GW; Manno JE; Cockerham KR; Manno BR
    J Anal Toxicol; 1990; 14(3):149-53. PubMed ID: 1973747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine isomers on central serotonergic, dopaminergic and nigral neurotensin systems of the rat.
    Johnson M; Letter AA; Merchant K; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1988 Mar; 244(3):977-82. PubMed ID: 2472482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain.
    Stone DM; Stahl DC; Hanson GR; Gibb JW
    Eur J Pharmacol; 1986 Aug; 128(1-2):41-8. PubMed ID: 2875893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of dopamine release by methylenedioxymethamphetamine is mediated by serotonin.
    Gazzara RA; Takeda H; Cho AK; Howard SG
    Eur J Pharmacol; 1989 Sep; 168(2):209-17. PubMed ID: 2575036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
    Battaglia G; Yeh SY; O'Hearn E; Molliver ME; Kuhar MJ; De Souza EB
    J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concentrations and ratios of amphetamine, methamphetamine, MDA, MDMA, and MDEA enantiomers determined in plasma samples from clinical toxicology and driving under the influence of drugs cases by GC-NICI-MS.
    Peters FT; Samyn N; Wahl M; Kraemer T; De Boeck G; Maurer HH
    J Anal Toxicol; 2003; 27(8):552-9. PubMed ID: 14670133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of inducers and inhibitors on the metabolism in vitro and neurochemical effects in vivo of MDMA.
    Gollamudi R; Ali SF; Lipe G; Newport G; Webb P; Lopez M; Leakey JE; Kolta M; Slikker W
    Neurotoxicology; 1989; 10(3):455-66. PubMed ID: 2576302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans.
    Hysek CM; Simmler LD; Ineichen M; Grouzmann E; Hoener MC; Brenneisen R; Huwyler J; Liechti ME
    Clin Pharmacol Ther; 2011 Aug; 90(2):246-55. PubMed ID: 21677639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.